The Carlyle Group CapEx decreased by 33.1% to $28.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 68.3%, from $16.70M to $28.10M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 24.5% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.90M | $9.40M | $14.40M | $12.30M | $5.10M | $7.60M | $15.60M | $12.90M | $19.60M | $17.10M | $17.00M | $14.20M | $17.70M | $19.10M | $26.70M | $16.70M | $17.50M | $23.20M | $42.00M | $28.10M |
| QoQ Change | — | +19.0% | +53.2% | -14.6% | -58.5% | +49.0% | +105.3% | -17.3% | +51.9% | -12.8% | -0.6% | -16.5% | +24.6% | +7.9% | +39.8% | -37.5% | +4.8% | +32.6% | +81.0% | -33.1% |
| YoY Change | — | — | — | — | -35.4% | -19.1% | +8.3% | +4.9% | +284.3% | +125.0% | +9.0% | +10.1% | -9.7% | +11.7% | +57.1% | +17.6% | -1.1% | +21.5% | +57.3% | +68.3% |